BridgeMD
New treatment option for Colorectal Surgery
Official title Impact of Ambulatory Continuous Monitoring Using Remote Monitoring Medicine Within Patient's Care Pathway Following Colorectal Surgery (CONTACT-GRECCAR 21)
ClinicalTrials.gov ID: NCT06850688
What this study is testing
- What it's testing
- The goal of this Clinical Investigation is to evaluate the effectiveness of implementing the discharge protocol of the remote monitoring platform after colorectal surgery in patients at risk of hospital readmission. Participants will be randomized into either the "30 days of remote monitoring" group or the "conventional discharge" group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Man or woman over 18 years old at the time of the J0 visit,
- Patient who underwent surgery less than 28 days ago, or who is scheduled to undergo colorectal surgery not managed as an outpatient procedure at the...
- At least one of the following two criteria:
- Anticipated early discharge (within 24 hours following laparoscopic surgery without stoma and without diversion, and within 5 days following...
- Estimated risk of hospital readmission greater than 10% according to the nomogram of Tevis et al. [15], adapted to the postoperative context in...
You likely can't join if
- Discharge to a rehabilitation center requested by the patient,
- Condition managed on an outpatient basis in routine practice for this type of patient,
- Patient eligible for home hospitalization services,
- Suicidal or hetero-aggressive risk in a patient living alone at home
- Homeless patient,
- Pregnant or breastfeeding women,
See the full eligibility criteria
- Man or woman over 18 years old at the time of the J0 visit,
- Patient who underwent surgery less than 28 days ago, or who is scheduled to undergo colorectal surgery not managed as an outpatient procedure at the investigational center, including resection of at least one colonic or...
- At least one of the following two criteria:
- Anticipated early discharge (within 24 hours following laparoscopic surgery without stoma and without diversion, and within 5 days following laparotomy and/or surgery with stoma and/or rectal surgery) for a procedure...
- Estimated risk of hospital readmission greater than 10% according to the nomogram of Tevis et al. [15], adapted to the postoperative context in digestive surgery (\>120 points according to this score).
- Patient affiliated with a health insurance plan,
- Patient who has signed the study consent form.
- Discharge to a rehabilitation center requested by the patient,
- Condition managed on an outpatient basis in routine practice for this type of patient,
- Patient eligible for home hospitalization services,
- Suicidal or hetero-aggressive risk in a patient living alone at home
- Homeless patient,
- Pregnant or breastfeeding women,
- Patient under legal guardianship, curatorship, or protected legal status,
- Patient already enrolled in an treatment postoperative follow-up study.
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
- Bordeaux, France
- Grenoble, France
- Lyon, France
- Marseille, France
- Nantes, France
- Paris, France
- Rennes, France
- Saint-Nazaire, France
- Toulouse, France
- Tours, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France; Bordeaux, France; Grenoble, France; Lyon, France; Marseille, France; Nantes, France and 5 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.